Vertex Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Vertex Pharmaceuticals
Results: 56

#	Item
31	FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Language: English Anilides Ivacaftor Phenols Quinolones Vertex Pharmaceuticals Cystic fibrosis Cystic Fibrosis Foundation Methadone Health Chemistry Organic chemistry
32	FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Pharmacology Vertex Pharmaceuticals Ivacaftor Center for Drug Evaluation and Research Cystic fibrosis Dermatologic and Ophthalmic Drugs Advisory Committee Health Food and Drug Administration Medicine
33	JOSH BOGER Dr. Joshua Boger is the founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). He retired as Vertex’s Chief Executive Officer and continues to serve on the Board. Dr. Boger holds a bachelor of arts i Add to Reading List Source URL: masschallenge.org Language: English - Date: 2014-10-24 17:43:42 Higher education Massachusetts Institute of Technology Education in the United States Academia New England Association of Schools and Colleges Harvard University Harvard Board of Overseers
34	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Ivacaftor Phenols Quinolones Cystic fibrosis Medicine Biology Vertex Pharmaceuticals VX-809 Health Pancreas disorders Anilides
35	JOINTLY SPONSORED BY This activity is supported by educational grants from Gilead Sciences, Merck & Co., and Vertex Pharmaceuticals. WELCOME Thank you for joining us for the inaugural International Conference on Viral Add to Reading List Source URL: www.iapac.org Language: English - Date: 2013-04-03 01:24:46 Gilead Sciences Boehringer Ingelheim Hepatitis C virus Johns Hopkins University Johns Hopkins School of Medicine Pharmaceutical industry Technology Economy of the United States Bristol-Myers Squibb Stuart C. Ray Pharmasset
36	August 11, 2014 Subject: Discontinuation of INCIVEK® (telaprevir) tablets in the United States Dear Healthcare Provider: The purpose of this letter is to inform you that Vertex Pharmaceuticals Incorporated will be disco Add to Reading List Source URL: freepdfhosting.com Language: English - Date: 2014-08-12 10:35:02 Triazoles Pharmacology Telaprevir Cytokines Interferon Biology Medicine Hepatitis C Boceprevir Antivirals Protease inhibitors Ribavirin
37	39 Years of Research, Education & Support Summer 2014 Diagnosis Fibrosis Quística: Meeting the Needs of Add to Reading List Source URL: www.cfri.org Language: English - Date: 2014-06-12 16:01:28 Medicine Biology Channelopathy Cystic fibrosis Cystic Fibrosis Foundation ΔF508 Ivacaftor VX-809 Vertex Pharmaceuticals Health Pediatrics Rare diseases
38	June 24, 2014 Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have Two Add to Reading List Source URL: files.shareholder.com Language: English Phenols Clinical research Cystic fibrosis Pediatrics Ivacaftor Vertex Pharmaceuticals Placebo Statin Health Medicine Biology
39	PRIOR AUTHORIZATION POLICY Kalydeco® (ivacaftor tablets Vertex) To Initiate a Coverage Review, Call[removed] Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-04-24 08:24:08 Anilides Ivacaftor Phenols Quinolones Pancreas disorders Cystic fibrosis ΔF508 VX-809 Vertex Pharmaceuticals Biology Health Genetics
40	WEEK OF OCTOBER 4, 2010 BioCentury THE BERNSTEIN REPORT ON BIOBUSINESS Volume 18 Number 43 Page A1 of 35 Add to Reading List Source URL: www.biocenturytv.com Language: English - Date: 2010-10-07 15:56:00 Pharmaceuticals policy NASDAQ NASDAQ Biotechnology Index Amgen Pharmaceutical industry in India Vertex Pharmaceuticals Alexion Pharmaceuticals Prescription Drug User Fee Act BioLineRx Pharmaceutical industry Economy of the United States Technology

UPDATE